Richard Vines, chairman and chief executive of Rare Cancers Australia, sat down with PharmaDispatch to mark the organisation's four year anniversary, to discuss its creation, achievements and the future. …
Richard Vines: Equity should be a reason to fund access, not an excuse to deny it
August 1, 2016 BioPharmaDispatch Executive
Latest Video
New Stories
-
Groups welcome wider access to shingles vaccine for immunocompromised patients
September 6, 2024 - - Latest News -
CSL announces sale of Wuhan plasma collection and fractionation operations
September 5, 2024 - - Latest News -
The 'Week in Review' Podcast - 6 September
September 5, 2024 - - Podcast -
Pfizer-backed initiative boosts Aboriginal and Torres Strait Islander pharmacy leadership
September 5, 2024 - - Latest News -
An increasingly busy ministerial agenda risks squeezing out other issues
September 5, 2024 - - Latest News -
Groups collaborate on the development of new opioid safety toolkit
September 5, 2024 - - Latest News -
Government still working towards first formal agreement with wholesalers
September 5, 2024 - - Latest News